ArticleEndocrine connections2026
Free testosterone and IGF-I mediate sex-specific linear growth during minipuberty.
Article in Endocrine connections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02784184 (COPENHAGEN Minipuberty Study), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
COPENHAGEN Minipuberty Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Postnatal growth velocity peaks in early infancy with transient sex differences, and about 15% of adult height is gained in the first year. This period overlaps with minipuberty, the temporary activation of the hypothalamic-pituitary-gonadal axis. Although minipuberty is critical for reproductive development, its role in somatic growth and its interaction with IGF-I remain unclear. We investigated (i) the relationship between free testosterone (free T) and growth velocity in early infancy, (ii) sex differences in these associations, and (iii) whether IGF-I mediates these effects. Design: Prospective, longitudinal, population-based birth cohort study (Copenhagen Minipuberty Study, 2016-2018 (ClinicalTrials.gov identifier NCT02784184); one-year follow-up). Methods: A total of 189 healthy, full-term, appropriate-for-gestational-age infants (88 girls and 101 boys) were followed from birth with repeated anthropometric and hormonal assessments up to 12 months of age. Results: After birth, growth velocity declined in both sexes, with boys growing faster during the first three months before trajectories converged. Free T was positively associated with growth velocity, most strongly in boys. In boys, shifting free T from the 25th to 75th percentile corresponded to an 8.3 cm/year higher growth velocity (95% CI: 3.5-15.3), of which 32.6% (95% CI: 15.3-85.3) was mediated via IGF-I. In girls, indirect effects via IGF-I were modest (0.8 cm/year, 95% CI: 0.05-1.8), while direct effects were not significant. Conclusion: Free testosterone contributes to early postnatal growth both directly and indirectly via IGF-I, with stronger effects in boys. These findings underscore sex-specific endocrine regulation of infant growth and suggest that androgen activity during minipuberty may influence long-term growth trajectories. Significance statement: During the first months of life, boys grow faster than girls, but the hormonal mechanisms underlying this difference are not well understood. This study shows that free testosterone during minipuberty contributes to early linear growth, particularly in boys, and that part of this association is mediated through IGF-I. By combining longitudinal growth data with serum hormone measurements, our findings identify an early interaction between androgen activity and the IGF-I axis. These results extend established concepts of sex steroid-dependent growth to infancy and highlight minipuberty as an important period for somatic growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.